Oct 23, 2026 03:34PM
Oct 23, 2026 03:33PM
Oct 18, 2026 06:10PM
Oct 18, 2026 06:10PM
Oct 17, 2026 08:17AM
Oct 17, 2026 02:00AM
Oct 13, 2026 03:15PM AbbVie Skyrizi shows endoscopic gains in Crohn's disease trial
Oct 13, 2026 03:15PM
Oct 11, 2026 01:00PM
Oct 7, 2026 08:32AM
Oct 7, 2026 08:30AM
Oct 5, 2026 02:54PM
Oct 1, 2026 10:01AM
Oct 1, 2026 10:00AM AbbVie Presents Long-Term RINVOQ® (upadacitinib) Data Showing Continued Repigmentation in Non-Segmental Vitiligo
Sep 30, 2026 06:00AM
Sep 30, 2026 01:00AM
Sep 28, 2026 08:00AM
Sep 28, 2026 08:00AM
Sep 22, 2026 08:00AM
Sep 18, 2026 08:31AM
Sep 18, 2026 08:30AM AbbVie Highlights New Real-World Data Supporting the Effectiveness of VRAYLAR® (cariprazine) at Psych Congress 2026
Sep 10, 2026 08:55AM
Sep 10, 2026 08:55AM
Sep 1, 2026 08:05AM
Aug 27, 2026 06:00AM
Aug 27, 2026 02:00AM
Aug 18, 2026 12:57PM
Aug 12, 2026 09:15AM The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
Aug 4, 2026 09:05AM
Aug 4, 2026 08:01AM
Aug 4, 2026 08:00AM
Jul 31, 2026 07:47AM
Jul 30, 2026 08:00AM
Jul 29, 2026 03:00AM
Jul 29, 2026 03:00AM AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo
Jul 29, 2026 03:00AM
Jul 23, 2026 04:00PM
Jul 23, 2026 04:00PM
Jul 14, 2026 08:05AM
Jul 14, 2026 08:05AM
Jul 1, 2026 09:05AM
Jun 29, 2026 04:20PM FDA selects 7 companies for domestic drug manufacturing pilot
Jun 29, 2026 04:15PM
Jun 29, 2026 04:15PM
Jun 29, 2026 03:10AM
Jun 29, 2026 03:10AM
Jun 29, 2026 03:00AM
Jun 29, 2026 03:00AM
Jun 26, 2026 04:52PM FDA approves AbbVie's Skyrizi for children with psoriatic disease
Jun 26, 2026 04:50PM

335,219 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All